Chronic infections in hip arthroplasties: Comparing risk of reinfection following one-stage and two-stage revision: A systematic review and meta-analysis

Clinical Epidemiology

Volumn 4, Issue 1, 2012, Pages 57-73

  Lange, Jeppe ^a,b   Troelsen, Anders ^c   Thomsen, Reimar W ^d   Søballe, Kjeld ^a,d  

^a Lundbeck Foundation Center for Fast Track Hip and Knee Surgery   (Denmark)

^b SILKEBORG REGIONAL HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Arthroplasty; Hip replacement; Infection; One stage; Reoperation; Two stage

Indexed keywords

COHORT ANALYSIS; CONFIDENCE INTERVAL; EMBASE; HIP ARTHROPLASTY; HUMAN; INFORMATION PROCESSING; MEDLINE; META ANALYSIS (TOPIC); METHODOLOGY; PATIENT SELECTION; PROSPECTIVE STUDY; PROSTHESIS INFECTION; REIMPLANTATION; REINFECTION RISK; REVIEW; RISK; RISK ASSESSMENT; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

EID: 84859471707     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S29025     Document Type: Review

References (94)

1. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009;91:128-133.
2. Zhan C, Kaczmarek R, Loyo-Berrios N, Sangl J, Bright RA. Incidence and short-term outcomes of primary and revision hip replacement in the United States. J Bone Joint Surg Am. 2007;89:526-533.
3. Hooper GJ, Rothwell AG, Stringer M, Frampton C. Revision following cemented and uncemented primary total hip replacement: a seven-year analysis from the New Zealand Joint Registry. J Bone Joint Surg Br. 2009;91:451-458.
4. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23:984-991.
5. Urquhart DM, Hanna FS, Brennan SL, et al. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty. 2010;25:1216-1222.
6. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-785.
7. Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009;467: 2606-2612.
8. Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med. 2009;361:787-794.
9. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-1654.
10. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am. 1998;80:1306-1313.
11. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996;78:512-523.
12. Theis JC. Implant retention in infected joint replacements: a surgeon's perspective. Int J Artif Organs. 2008;31:804-809.
13. Hanssen AD, Osmon DR. Evaluation of a staging system for infected hip arthroplasty. Clin Orthop Relat Res. 2002;403:16-22.
14. Fink B. Revision of late periprosthetic infections of total hip endo-prostheses: pros and cons of different concepts. Int J Med Sci. 2009;6: 287-295.
15. Winkler H. Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft. Int J Med Sci. 2009;6:247-252.
16. Cabrita HB, Croci AT, Camargo OP, Lima AL. Prospective study of the treatment of infected hip arthroplasties with or without the use of an antibiotic-loaded cement spacer. Clinics (Sao Paulo). 2007;62: 99-108.
17. Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg Br. 1981;63-B:342-353.
18. Jackson WO, Schmalzried TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res. 2000;381:101-105.
19. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006-1012.
20. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-e34.
21. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323:224-228.
22. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Chichester, UK: Wiley; 2009.
23. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
24. Lin J, Yang X, Bostrom MP. Two-stage exchange hip arthroplasty for deep infection. J Chemother. 2001;13 Spec 1:54-65.
25. Cierny G, DiPasquale D. Treatment of chronic infection. J Am Acad Orthop Surg. 2006;14:S105-S110.
26. Anagnostakos K, Schmid NV, Kelm J, Grun U, Jung J. Classification of hip joint infections. Int J Med Sci. 2009;6:227-233.
27. Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007;89:871-882.
28. Moyad TF, Thornhill T, Estok D. Evaluation and management of the infected total hip and knee. Orthopedics. 2008;31:581-588.
29. Salvati EA, González Della Valle A, Masri BA, Duncan CP. The infected total hip arthroplasty. Instr Course Lect. 2003;52:223-245.
30. Mitchell PA, Masri BA, Garbuz DS, Greidanus NV, Duncan CP. Cementless revision for infection following total hip arthroplasty. Instr Course Lect. 2003;52:323-330.
31. Haddad FS, Masri BA, Garbuz DS, Duncan CP. The treatment of the infected hip replacement. The complex case. Clin Orthop Relat Res. 1999:144-156.
32. Sukeik M, Haddad FS. Two-stage procedure in the treatment of late chronic hip infections-spacer implantation. Int J Med Sci. 2009;6: 253-257.
33. Friesecke C, Wodtke J. Management of periprosthetic infection. Chirurg. 2008;79:777-792. German.
34. Duncan CP, Masri BA. The role of antibiotic-loaded cement in the treatment of an infection after a hip replacement. Instr Course Lect. 1995;44:305-313.
35. Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect. 1999;48:111-122.
36. Garvin KL, Hanssen AD. Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am. 1995;77:1576-1588.
37. Hanssen AD, Spangehl MJ. Treatment of the infected hip replacement. Clin Orthop Relat Res. 2004;420:63-71.
38. Kaltsas DS. Infection after total hip arthroplasty. Ann R Coll Surg Engl. 2004;86:267-271.
39. Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother. 2004;53:127-129.
40. Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg Br. 2003;85: 637-640.
41. Lehner B, Witte D, Suda AJ, Weiss S. Revision strategy for periprosthetic infection. Orthopade. 2009;38:681-688.
42. Matthews PC, Berendt AR, McNally MA, Byren I. Diagnosis and management of prosthetic joint infection. BMJ. 2009;338:b1773.
43. Ruchholtz S, Tager G, Nast-Kolb D. The infected hip prosthesis. Unfallchirurg. 2004;107:307-317.
44. Maderazo EG, Judson S, Pasternak H. Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res. 1988;229:131-142.
45. Toms AD, Davidson D, Masri BA, Duncan CP. The management of peri-prosthetic infection in total joint arthroplasty. J Bone Joint Surg Br. 2006;88:149-155.
46. Masterson EL, Masri BA, Duncan CP. Treatment of infection at the site of total hip replacement. Instr Course Lect. 1998;47:297-306.
47. Yoo JJ, Kwon YS, Koo KH, Yoon KS, Kim YM, Kim HJ. One-stage cementless revision arthroplasty for infected hip replacements. Int Orthop. 2009;33:1195-1201.
48. Lai KA, Yang CY, Lin RM, Jou IM, Lin CJ. Cementless reimplantation of hydroxyapatite-coated total hips after periprosthetic infections. J Formos Med Assoc. 1996;95:452-457.
49. Rudelli S, Uip D, Honda E, Lima AL. One-stage revision of infected total hip arthroplasty with bone graft. J Arthroplasty. 2008;23:1165-1177.
50. Mulcahy DM, O'Byrne JM, Fenelon GE. One stage surgical management of deep infection of total hip arthroplasty. Ir J Med Sci. 1996;165:17-19.
51. Callaghan JJ, Katz RP, Johnston RC. One-stage revision surgery of the infected hip. A minimum 10-year followup study. Clin Orthop Relat Res. 1999;369:139-143.
52. Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br. 1989;71:851-855.
53. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am. 1998;80:961-968.
54. Raut VV, Siney PD, Wroblewski BM. One-stage revision of total hip arthroplasty for deep infection. Long-term followup. Clin Orthop Relat Res. 1995:202-207.
55. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother. 1993;37: 1214-1218.
56. Buttaro MA, Pusso R, Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br. 2005;87:314-319.
57. Fehring TK, Calton TF, Griffin WL. Cementless fixation in 2-stage reimplantation for periprosthetic sepsis. J Arthroplasty. 1999;14: 175-181.
58. Fink B, Grossmann A, Fuerst M, Schafer P, Frommelt L. Two-stage cementless revision of infected hip endoprostheses. Clin Orthop Relat Res. 2009;467:1848-1858.
59. Hofmann AA, Goldberg TD, Tanner AM, Cook TM. Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty. 2005;20:874-879.
60. Koo KH, Yang JW, Cho SH, et al. Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty. 2001;16:882-892.
61. Yamamoto K, Miyagawa N, Masaoka T, Katori Y, Shishido T, Imakiire A. Clinical effectiveness of antibiotic-impregnated cement spacers for the treatment of infected implants of the hip joint. J Orthop Sci. 2003;8:823-828.
62. Nestor BJ, Hanssen AD, Ferrer-Gonzalez R, Fitzgerald RH. The use of porous prostheses in delayed reconstruction of total hip replacements that have failed because of infection. J Bone Joint Surg Am. 1994;76: 349-359.
63. McDonald DJ, Fitzgerald RH, Ilstrup DM. Two-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am. 1989;71:828-834.
64. Cordero-Ampuero J, Esteban J, Garcia-Cimbrelo E. Oral antibiotics are effective for highly resistant hip arthroplasty infections. Clin Orthop Relat Res. 2009;467:2335-2342.
65. Evans RP. Successful treatment of total hip and knee infection with articulating antibiotic components: a modified treatment method. Clin Orthop Relat Res. 2004;427:37-46.
66. Magnan B, Regis D, Biscaglia R, Bartolozzi P. Preformed acrylic bone cement spacer loaded with antibiotics: use of two-stage procedure in 10 patients because of infected hips after total replacement. Acta Orthop Scand. 2001;72:591-594.
67. Dairaku K, Takagi M, Kawaji H, Sasaki K, Ishii M, Ogino T. Antibiotics-impregnated cement spacers in the first step of two-stage revision for infected totally replaced hip joints: report of ten trial cases. J Orthop Sci. 2009;14:704-710.
68. Nusem I, Morgan DA. Structural allografts for bone stock reconstruction in two-stage revision for infected total hip arthroplasty: good outcome in 16 of 18 patients followed for 5-14 years. Acta Orthop. 2006;77:92-97.
69. Lieberman JR, Callaway GH, Salvati EA, Pellicci PM, Brause BD. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res. 1994;301:205-212.
70. Sanchez-Sotelo J, Berry DJ, Hanssen AD, Cabanela ME. Midterm to long-term followup of staged reimplantation for infected hip arthroplasty. Clin Orthop Relat Res. 2009;467:219-224.
71. Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008;90:145-148.
72. Incavo SJ, Russell RD, Mathis KB, Adams H. Initial results of managing severe bone loss in infected total joint arthroplasty using customized articulating spacers. J Arthroplasty. 2009;24:607-613.
73. Lim SJ, Park JC, Moon YW, Park YS. Treatment of periprosthetic hip infection caused by resistant microorganisms using 2-stage reimplantation protocol. J Arthroplasty. 2009;24:1264-1269.
74. Wang JW, Chen CE. Reimplantation of infected hip arthroplasties using bone allografts. Clin Orthop Relat Res. 1997:202-210.
75. Whittaker JP, Warren RE, Jones RS, Gregson PA. Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection? J Bone Joint Surg Br. 2009;91: 44-51.
76. Scharfenberger A, Clark M, Lavoie G, O'Connor G, Masson E, Beaupre LA. Treatment of an infected total hip replacement with the PROSTALAC system. Part 1: Infection resolution. Can J Surg. 2007;50:24-28.
77. Walter G, Buhler M, Hoffmann R. Two-stage procedure to exchange septic total hip arthroplasties with late periprosthetic infection. Early results after implantation of a reverse modular hybrid endoprosthesis. Unfallchirurg. 2007;110:537-546.
78. Takigami I, Ito Y, Ishimaru D, et al. Two-stage revision surgery for hip prosthesis infection using antibiotic-loaded porous hydroxyapatite blocks. Arch Orthop Trauma Surg. 2010;130:1221-1226.
79. Isiklar ZU, Demirors H, Akpinar S, Tandogan RN, Alparslan M. Two-stage treatment of chronic staphylococcal orthopaedic implantrelated infections using vancomycin impregnated PMMA spacer and rifampin containing antibiotic protocol. Bull Hosp Jt Dis. 1999;58: 79-85.
80. Scharfenberger A, Clark M, Lavoie G, O'Connor G, Masson E, Beaupre LA. Treatment of an infected total hip replacement with the PROSTALAC system. Part 2: Health-related quality of life and function with the PROSTALAC implant in situ. Can J Surg. 2007;50:29-33.
81. Lang JM, Rothman KJ, Cann CI. That confounded P-value. Epidemiology. 1998;9:7-8.
82. Kamme C, Lindberg L. Aerobic and anaerobic bacteria in deep infections after total hip arthroplasty: differential diagnosis between infectious and non-infectious loosening. Clin Orthop Relat Res. 1981; 154:201-207.
83. Atkins BL, Athanasou N, Deeks JJ, et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol. 1998;36:2932-2939.
84. Fitzgerald RH, Nolan DR, Ilstrup DM, Van Scoy RE, Washington JA, Coventry MB. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am. 1977;59:847-855.
85. Cierny G, DiPasquale D. Periprosthetic total joint infections: staging, treatment, and outcomes. Clin Orthop Relat Res. 2002;403: 23-28.
86. Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am. 1975;6:991-1003.
87. Della Valle CJ, Zuckerman JD, Cesare PE. Periprosthetic sepsis. Clin Orthop Relat Res. 2004;420:26-31.
88. McPherson EJ, Woodson C, Holtom P, Roidis N, Shufelt C, Patzakis M. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res. 2002;403:8-15.
89. McPherson EJ, Tontz W Jr, Patzakis M, et al. Outcome of infected total knee utilizing a staging system for prosthetic joint infection. Am J Orthop. 1999;28:161-165.
90. Oussedik SI, Haddad FS. The use of linezolid in the treatment of infected total joint arthroplasty. J Arthroplasty. 2008;23:273-278.
91. Jung J, Schmid NV, Kelm J, Schmitt E, Anagnostakos K. Complications after spacer implantation in the treatment of hip joint infections. Int J Med Sci. 2009;6:265-273.
92. Pedersen AB, Svendsson JE, Johnsen SP, Riis A, Overgaard S. Risk factors for revision due to infection after primary total hip arthroplasty. A population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry. Acta Orthop. 2010;81:542-547.
93. Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, Soballe K. Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study. Bone. 2010;46:946-951.
94. Parvizi J, Ghanem E, Azzam K, Davis E, Jaberi F, Hozack W. Periprosthetic infection: are current treatment strategies adequate? Acta Orthop Belg. 2008;74:793-800.